PPT2: COST ANALYSIS OF PROPHYLACTIC TREATMENT OF CHILDREN WITH SEVERE HEMOPHILIA A IN CANADAThe aim of this study is to evaluate the accumulation and biodistribution of 99mTc-labeled chitosan nanoparticles (Chi NPs) containing an angiogenic factor after intra-arterial injection and to investigate their...
Updates From the 2015 Meetings in Hemophilia Program Goal Prophylaxis: History and Challenges Prophylaxis in Adults: The SPINART Trial Stopping Prophylaxis: What Are the Consequences?a Factor VIII Prophylaxis: Long-term Outcomes Trough Levels and Joint Bleeds Extended Half-life Products: Factor IX (FI...